Citation

Jiangping W, Shijun X (2019) Prevention and Treatment of Basic Diseases: A Potential Direction to Intervene Alzheimer's Disease. Int J Neurol Neurother 6:084. doi.org/10.23937/2378-3001/1410084

Copyright

© 2019 Jiangping W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

REVIEW ARTICLE | OPEN ACCESS DOI: 10.23937/2378-3001/1410084

Prevention and Treatment of Basic Diseases: A Potential Direction to Intervene Alzheimer's Disease

Wei Jiangping1,2 and Xu Shijun1,2*

1School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China

2Institute of Meterial Medica Integration and Transformation for Brain Disorders, CDUTCM, China

Abstract

As the life span of human beings increases, the number of dementia patients such as Alzheimer's disease (AD) is increasing. AD may be one of the major diseases faced by the whole world in the future. It is an unresponsive for single drug according to the current stage of AD pathogenesis and drug research. Combined use of various drugs may be the inevitable trend of AD drug research in the future. Personalized treatment of metabolic diseases, vascular diseases and chronic inflammatory risk diseases is a necessary step to intervene in AD. During the middle age, to strengthen immunity and to reduce the external environment to stimulate the susceptible gene, which is beneficial to suppress the formation of AD. In a word, the early prevention of AD is better than the later treatment.